Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

GX-015-070 enters phase I

Nov. 9, 2004

Phase II trials in Canada, E.U. evaluate AMD-3100 for stem cell transplantation

Nov. 9, 2004

Phenoxodiol receives fast track status for recurrent ovarian cancer

Nov. 9, 2004

New approval for Eloxatin

Nov. 9, 2004

Histone deacetylase inhibitor effective against esophageal carcinoma in vitro

Nov. 9, 2004

Taxotere approved in E.U. for prostate cancer

Nov. 8, 2004

Natural protease inhibitors may enhance chemotherapeutic efficacy

Nov. 8, 2004

Novel TGF-beta receptor type II kinase inhibitors claimed by Pfizer

Nov. 8, 2004

New inhibitors of PDE4, MMP and/or TNF-alpha discovered at Celgene

Nov. 8, 2004

New anticancer and immunostimulant agent isolated from plants by Japanese team

Nov. 8, 2004

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...